These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1500342)

  • 1. Isolation and characterization of sporeamicin C.
    Morishita A; Murofushi S; Ishizawa K; Mutoh N; Yaginuma S
    J Antibiot (Tokyo); 1992 Jun; 45(6):1011-5. PubMed ID: 1500342
    [No Abstract]   [Full Text] [Related]  

  • 2. Sporeamicin A, a new macrolide antibiotic. I. Taxonomy, fermentation, isolation and characterization.
    Yaginuma S; Morishita A; Ishizawa K; Murofushi S; Hayashi M; Mutoh N
    J Antibiot (Tokyo); 1992 May; 45(5):599-606. PubMed ID: 1624360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of sporeamicin B.
    Morishita A; Murofushi S; Ishizawa K; Mutoh N; Yaginuma S
    J Antibiot (Tokyo); 1992 May; 45(5):809-12. PubMed ID: 1624386
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel erythromycins from a recombinant Saccharopolyspora erythraea strain NRRL 2338 pIG1. I. Fermentation, isolation and biological activity.
    Pacey MS; Dirlam JP; Geldart RW; Leadlay PF; McArthur HA; McCormick EL; Monday RA; O'Connell TN; Staunton J; Winchester TJ
    J Antibiot (Tokyo); 1998 Nov; 51(11):1029-34. PubMed ID: 9918396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of 6-deoxy-13-cyclopropyl-erythromycin B by Saccharopolyspora erythraea NRRL 18643.
    Brown MS; Dirlam JP; McArthur HA; McCormick EL; Morse BK; Murphy PA; O'Connell TN; Pacey M; Rescek DM; Ruddock J; Wax RG
    J Antibiot (Tokyo); 1999 Aug; 52(8):742-7. PubMed ID: 10580387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and structure of a new macrolide antibiotic, erythromycin G, and a related biosynthetic intermediate from a culture of Saccharopolyspora erythraea.
    Cevallos A; Guerriero A
    J Antibiot (Tokyo); 2003 Mar; 56(3):280-8. PubMed ID: 12760684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sporeamicin A, a new macrolide antibiotic. III. Biological properties.
    Morishita A; Mutoh N; Ishizawa K; Suzuki T; Yokoiyama S; Yaginuma S
    J Antibiot (Tokyo); 1992 May; 45(5):613-7. PubMed ID: 1624362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of 7-hydroxy-6-demethyl-6-deoxy-erythromycin D, a new erythromycin analogue, from engineered Saccharopolyspora erythraea.
    Starks CM; Rodriguez E; Carney JR; Desai RP; Carreras C; McDaniel R; Hutchinson R; Galazzo JL; Licari PJ
    J Antibiot (Tokyo); 2004 Jan; 57(1):64-7. PubMed ID: 15032488
    [No Abstract]   [Full Text] [Related]  

  • 9. Structural elucidation of a novel erythromycin, 13-cyclopentyl-13-desethyl-erythromycin B, from a recombinant Saccharopolyspora erythraea strain, NRRL 2338 pIG/1.
    Parsons IC; Everett JR; Pacey MS; Ruddock JC; Swanson AG; Thompson CM
    J Antibiot (Tokyo); 1999 Feb; 52(2):190-2. PubMed ID: 10344576
    [No Abstract]   [Full Text] [Related]  

  • 10. [Molecularly imprinted hydrophilic polymer sorbents for selective sorption of erythromycin].
    Ezhova NM; Garkushina IS; Pisarev OA
    Prikl Biokhim Mikrobiol; 2011; 47(6):694-8. PubMed ID: 22288199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combinatorial biosynthesis of 5-O-desosaminyl erythronolide A as a potent precursor of ketolide antibiotics.
    Basnet DB; Park JW; Yoon YJ
    J Biotechnol; 2008 May; 135(1):92-6. PubMed ID: 18430483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 8-Deoxylankolide from a lankamycin producing Streptomyces spp.
    Ju J; Goo YM
    J Antibiot (Tokyo); 1997 Aug; 50(8):690-2. PubMed ID: 9315083
    [No Abstract]   [Full Text] [Related]  

  • 13. Sporeamicin A, a new macrolide antibiotic. II. Structure determination.
    Morishita A; Ishizawa K; Mutoh N; Yamamoto T; Hayashi M; Yaginuma S
    J Antibiot (Tokyo); 1992 May; 45(5):607-12. PubMed ID: 1624361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel erythromycin, 6-desmethyl erythromycin D, made by substituting an acyltransferase domain of the erythromycin polyketide synthase.
    Petkovic H; Lill RE; Sheridan RM; Wilkinson B; McCormick EL; McArthur HA; Staunton J; Leadlay PF; Kendrew SG
    J Antibiot (Tokyo); 2003 Jun; 56(6):543-51. PubMed ID: 12931864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethyl-substituted erythromycin derivatives produced by directed metabolic engineering.
    Stassi DL; Kakavas SJ; Reynolds KA; Gunawardana G; Swanson S; Zeidner D; Jackson M; Liu H; Buko A; Katz L
    Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7305-9. PubMed ID: 9636144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete biosynthesis of erythromycin A and designed analogs using E. coli as a heterologous host.
    Zhang H; Wang Y; Wu J; Skalina K; Pfeifer BA
    Chem Biol; 2010 Nov; 17(11):1232-40. PubMed ID: 21095573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Construction of Saccharopolyspora erythraea M synthesizing a novel ketolide 3-deoxy-3-oxo-erythronolide B].
    Zhang BC; Zhao ZH; Wang YG; Ma QJ
    Sheng Wu Gong Cheng Xue Bao; 2002 Jan; 18(2):198-203. PubMed ID: 12148283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel fluorinated erythromycin antibiotic.
    Goss RJ; Hong H
    Chem Commun (Camb); 2005 Aug; (31):3983-5. PubMed ID: 16075093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxylation and N-demethylation of clarithromycin (6-O-methylerythromycin A) by Mucor circinelloides.
    Adachi T; Sasaki J; Omura S
    J Antibiot (Tokyo); 1989 Sep; 42(9):1433-7. PubMed ID: 2529234
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased erythromycin production by alginate as a medium ingredient or immobilization support in cultures of Saccharopolyspora erythraea.
    Hamedi J; Khodagholi F; Hassani-Nasab A
    Biotechnol Lett; 2005 May; 27(9):661-4. PubMed ID: 15977074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.